514
Views
8
CrossRef citations to date
0
Altmetric
Research Article

CP-MLR/PLS directed QSAR study on the glutaminyl cyclase inhibitory activity of imidazoles: rationales to advance the understanding of activity profile

, , &
Pages 515-522 | Received 18 Mar 2011, Accepted 29 Dec 2011, Published online: 05 Feb 2012
 

Abstract

The glutaminyl cyclase inhibitory activity of a series of imidazoles has been analyzed through combinatorial protocol in multiple linear regressions (CP-MLR) and partial least square using different topological and structural descriptors. The QC activity was found to be correlated with 2D-autocorrelation (2DAUTO) and atom centered fragments (ACF) descriptors. The descriptor from 2DAUTO class showed that molecular structure frames of one, six and seven path length associated with atomic van der Waals volumes and polarizability hold scope for modulating QC inhibitory activity. The ACF descriptors suggested that the unsubstituted alkyl fragments and methyl substituted imidazole ring are favorable, while unsaturation in the same and C=N-C≡N are unfavorable for activity. The molar refractivity (MR) is conducive for activity. The descriptors identified in the study collectively highlight the significance of molecular volume and polarizability to the QC inhibitory activity of imidazoles. The models are statistically significant and showed good predictivity.

Acknowledgement

Authors thank Director, CDRI, Lucknow and Chairman, ISF College of Pharmacy, Moga for the facilities to carry out the research work.

Declaration of interest

The authors report no conflicts of interest.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.